140 related articles for article (PubMed ID: 6548790)
1. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
Waldhorn RE; Tsou E; Smith FP; Kerwin DM
Med Pediatr Oncol; 1984; 12(6):394-6. PubMed ID: 6548790
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary hypertension, hemolytic anemia, and renal failure. A mitomycin-associated syndrome.
McCarthy JT; Staats BA
Chest; 1986 Apr; 89(4):608-11. PubMed ID: 3082608
[TBL] [Abstract][Full Text] [Related]
3. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
Jolivet J; Giroux L; Laurin S; Gruber J; Bettez P; Band PR
Cancer Treat Rep; 1983 May; 67(5):429-34. PubMed ID: 6406059
[TBL] [Abstract][Full Text] [Related]
4. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
Claycomb CL; Berkovic M
J Am Osteopath Assoc; 1986 Aug; 86(8):499-503. PubMed ID: 3093413
[No Abstract] [Full Text] [Related]
5. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Bouillet T; Lepage E; Gisselbrecht C; Boiron M
Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
[TBL] [Abstract][Full Text] [Related]
6. Reversible microangiopathic hemolytic anemia after mitomycin C.
Perry DJ
Cancer Chemother Pharmacol; 1983; 10(3):223. PubMed ID: 6407770
[No Abstract] [Full Text] [Related]
7. [Microangiopathic hemolytic anemia associated with gastric cancer].
Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
[TBL] [Abstract][Full Text] [Related]
8. Rash, nephritis, hypertension, and haemolysis in patient on 5-fluorouracil, doxorubicin, and mitomycin-C.
Karlin DA; Stroehlein JR
Lancet; 1980 Sep; 2(8193):534-5. PubMed ID: 6105582
[No Abstract] [Full Text] [Related]
9. Advanced gastric cancer: experience in Scotland using 5-fluorouracil, adriamycin and mitomycin-C.
Cunningham D; Soukop M; McArdle CS; Carter DC; Smyth JF; Allan SG; Kaye SB; Sangster G; Calman KC; Hutcheon AW
Br J Surg; 1984 Sep; 71(9):673-6. PubMed ID: 6548166
[TBL] [Abstract][Full Text] [Related]
10. [Three cases of renal failure associated with microangiopathic hemolytic anemia after mitomycin C therapy].
Hayano K; Fukui H; Otsuka Y; Hattori S
Nihon Jinzo Gakkai Shi; 1988 Jul; 30(7):835-42. PubMed ID: 3150472
[No Abstract] [Full Text] [Related]
11. Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Lise M; Nitti D; Buyse M; Cartei G; Fornasiero A; Guimaraes dos Santos J; Duez N
Recent Results Cancer Res; 1988; 110():36-43. PubMed ID: 3043595
[No Abstract] [Full Text] [Related]
12. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
[No Abstract] [Full Text] [Related]
13. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
[TBL] [Abstract][Full Text] [Related]
14. A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer.
Kim NK; Park YS; Heo DS; Suh C; Kim SY; Park KC; Kang YK; Shin DB; Kim HT; Kim HJ
Cancer; 1993 Jun; 71(12):3813-8. PubMed ID: 8508349
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for advanced pancreatic cancer. A comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM).
Oster MW; Gray R; Panasci L; Perry MC
Cancer; 1986 Jan; 57(1):29-33. PubMed ID: 2934124
[TBL] [Abstract][Full Text] [Related]
16. Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
Gupta S; Raina V; Jain P; Gujral S; Kumar R
J Assoc Physicians India; 2000 Jun; 48(6):639-40. PubMed ID: 11273547
[TBL] [Abstract][Full Text] [Related]
17. 5-fluorouracil, adriamycin, and mitomycin-C (FAM) combination chemotherapy in the treatment of advanced gastric cancer.
MacDonald JS; Woolley PV; Smythe T; Ueno W; Hoth D; Schein PS
Cancer; 1979 Jul; 44(1):42-7. PubMed ID: 455263
[TBL] [Abstract][Full Text] [Related]
18. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
Sheldon R; Slaughter D
Cancer; 1986 Oct; 58(7):1428-36. PubMed ID: 3091244
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
Cantrell JE; Phillips TM; Schein PS
J Clin Oncol; 1985 May; 3(5):723-34. PubMed ID: 3923162
[TBL] [Abstract][Full Text] [Related]
20. Further studies on the treatment of advanced gastric cancer by 5-fluorouracil, Adriamycin (doxorubicin), and mitomycin C (modified FAM).
Haim N; Epelbaum R; Cohen Y; Robinson E
Cancer; 1984 Nov; 54(9):1999-2002. PubMed ID: 6548173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
